PD Dr. Stefan Diem
Medizinische Onkologie und Hämatologie · Dept. I
Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma
Morganstein D, Lai Z, Spain L, Diem S, Levine D, Mace C, Gore M, Larkin J. Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma. Clin Endocrinol (Oxf) 2017; 86:614-620.
Jan 27, 2017Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma
Jan 27, 2017Clin Endocrinol (Oxf) 2017; 86:614-620
Morganstein D L, Lai Z, Spain L, Diem Stefan, Levine D, Mace C, Gore M, Larkin J
Thyroid Abnormalities following the use of CTLA-4 and PD-1 Inhibitors in the treatment of melanoma
Diem S. Thyroid Abnormalities following the use of CTLA-4 and PD-1 Inhibitors in the treatment of melanoma. Clinical endocrinology 2016
Dec 29, 2016Thyroid Abnormalities following the use of CTLA-4 and PD-1 Inhibitors in the treatment of melanoma
Dec 29, 2016Clinical endocrinology 2016
Diem Stefan
GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography
Hasan Ali O, Diem S, Aschwanden J, Markert E, Tasman A, Müller J, Flatz L. GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography. JAAD Case Rep 2016; 2:415-417.
Oct 13, 2016GLUT1-positive recurrent basal cell carcinoma of basosquamous subtype detected by positron emission tomography
Oct 13, 2016JAAD Case Rep 2016; 2:415-417
Hasan Ali Omar, Diem Stefan, Aschwanden Josef, Markert Eva, Tasman Abel-Jan, Müller Joachim, Flatz Lukas
Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer
Hasan Ali O, Diem S, Markert E, Jochum W, Kerl K, French L, Speiser D, Früh M, Flatz L. Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer. Oncoimmunology 2016; 5:e1231292.
Sep 19, 2016Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer
Sep 19, 2016Oncoimmunology 2016; 5:e1231292
Hasan Ali Omar, Diem Stefan, Markert Eva, Jochum Wolfram, Kerl Katrin, French Lars E, Speiser Daniel E, Früh Martin, Flatz Lukas
Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?
Diem S, Goldinger S, Urner-Bloch U, Siano M, Dummer R, Speiser D, Maillard S, Rüesch R, Keller F, Flatz L. Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?. J Immunother 2016; 39:379-382.
Jan 1, 2016Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?
Jan 1, 2016J Immunother 2016; 39:379-382
Diem Stefan, Goldinger Simone M, Urner-Bloch Ursula, Siano Marco, Dummer Reinhard, Speiser Daniel E, Maillard Samia A, Rüesch Reinhard, Keller Fabienne, Flatz Lukas
Prognostic score for patients with advanced melanoma treated with ipilimumab
Diem S. Prognostic score for patients with advanced melanoma treated with ipilimumab. European Journal of Cancer 2015
Nov 18, 2015Prognostic score for patients with advanced melanoma treated with ipilimumab
Nov 18, 2015European Journal of Cancer 2015
Diem Stefan
Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis
Diem S, Ess S, Cerny T, Früh M, Hitz F. Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis. Eur J Intern Med 2014; 25:577-82.
May 28, 2014Diffuse large B-cell lymphoma in elderly patients: a retrospective analysis
May 28, 2014Eur J Intern Med 2014; 25:577-82
Diem Stefan, Ess S, Cerny Thomas, Früh Martin, Hitz Felicitas
Diffuse large B-cell lymphoma in elderly patients: A retrospective analysis
Diem S. Diffuse large B-cell lymphoma in elderly patients: A retrospective analysis. European Journal of Internal Medicine 2014
May 28, 2014Diffuse large B-cell lymphoma in elderly patients: A retrospective analysis
May 28, 2014European Journal of Internal Medicine 2014
Diem Stefan
Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study
Jörger M, Schaer-Thuer C, Koeberle D, Matter-Walstra K, Gibbons-Marsico J, Diem S, Thürlimann B, Cerny T. Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study. Eur J Clin Pharmacol 2014; 70:719-25.
Mar 11, 2014Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study
Mar 11, 2014Eur J Clin Pharmacol 2014; 70:719-25
Jörger Markus, Schaer-Thuer C, Koeberle D, Matter-Walstra K, Gibbons-Marsico J, Diem Stefan, Thürlimann Beat, Cerny Thomas
Off-Label use of anti-cancer drugs in switzerland: A population based prospective cohort study
Diem S. Off-Label use of anti-cancer drugs in switzerland: A population based prospective cohort study. European journal of clinical pharmacology 2014
Feb 21, 2014Off-Label use of anti-cancer drugs in switzerland: A population based prospective cohort study
Feb 21, 2014European journal of clinical pharmacology 2014
Diem Stefan
Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
Hitz F, Diem S, Haile S, ess s, Cerny T, Mey U. Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematol Oncol 2013
Dec 11, 2013Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
Dec 11, 2013Hematol Oncol 2013
Hitz Felicitas, Diem Stefan, Haile Sarah, ess silvia, Cerny Thomas, Mey Ulrich
Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
Diem S. Outcome of mantle cell lymphoma patients treated at a single institution over the past decade. Hematological oncology 2013
Nov 16, 2013Outcome of mantle cell lymphoma patients treated at a single institution over the past decade
Nov 16, 2013Hematological oncology 2013
Diem Stefan
EML4-ALK-Positive Pulmonary Adenocarcinoma with an Unusual Metastatic Pattern: A Case Report
Diem S, Früh M, Rodriguez R, Liechti P, Rothermundt C. EML4-ALK-Positive Pulmonary Adenocarcinoma with an Unusual Metastatic Pattern: A Case Report. Case Rep Oncol 2013; 6:316-9.
Jun 13, 2013EML4-ALK-Positive Pulmonary Adenocarcinoma with an Unusual Metastatic Pattern: A Case Report
Jun 13, 2013Case Rep Oncol 2013; 6:316-9
Diem Stefan, Früh Martin, Rodriguez Regulo, Liechti Peter, Rothermundt Christian